Bustamante-Aragones Ana, Vallespin Elena, Rodriguez de Alba Marta, Trujillo-Tiebas Maria Jose, Gonzalez-Gonzalez Cristina, Diego-Alvarez Dan, Riveiro-Alvarez Rosa, Lorda-Sanchez Isabel, Ayuso Carmen, Ramos Carmen
Department of Genetics, Fundacion Jimenez Diaz-Capio, CIBERER, Madrid, Spain.
Mol Vis. 2008 Aug 4;14:1388-94.
Leber congenital amaurosis (LCA) is one of the most severe inherited retinal dystrophies with the earliest age of onset. Mutations in the Crumbs homologue 1 (CRB1; OMIM 600105) gene explain 10%-24% of cases with LCA depending on the population. The aim of the present work was to study a fetal mutation associated to LCA in maternal plasma by a new methodology in the noninvasive prenatal diagnosis field: the denaturing High Performance Liquid Chromatography (dHPLC).
This study presents the case of a compound heterozygous fetus for two mutations in CRB1 (1q3.1-q32.2). dHPLC and automated DNA sequencing were used to detect the paternally inherited fetal mutation in a maternal plasma sample collected at the 12th week of gestation. To test the detection limit of dHPLC, we made serial dilutions of paternal DNA in control DNA.
We were able to detect the presence of the paternally inherited fetal CRB1 mutation in maternal plasma by dHPLC. Moreover, by comparing chromatograms of serial dilutions to the plasma sample, we could ascertain that the percentage of fetal DNA in maternal plasma was at least 2%. However, the detection of the fetal mutation was not possible by automated DNA sequencing.
dHPLC seems to be sensitive enough to detect small amounts of fetal DNA in maternal plasma samples. It could be a useful tool for the noninvasive prenatal detection of paternally inherited point mutations associated with retinopathies.
莱伯先天性黑蒙(LCA)是最严重的遗传性视网膜营养不良之一,发病年龄最早。视黄醛结合蛋白1(CRB1;OMIM 600105)基因突变在不同人群中导致10%-24%的LCA病例。本研究的目的是通过非侵入性产前诊断领域的一种新方法——变性高效液相色谱法(dHPLC),研究母体血浆中与LCA相关的胎儿突变。
本研究报告了一例CRB1(1q3.1-q32.2)基因两个突变的复合杂合子胎儿病例。在妊娠第12周采集的母体血浆样本中,使用dHPLC和自动化DNA测序检测父系遗传的胎儿突变。为了测试dHPLC的检测限,我们在对照DNA中对父系DNA进行了系列稀释。
我们能够通过dHPLC检测母体血浆中父系遗传的胎儿CRB1突变的存在。此外,通过将系列稀释的色谱图与血浆样本进行比较,我们可以确定母体血浆中胎儿DNA的百分比至少为2%。然而,通过自动化DNA测序无法检测到胎儿突变。
dHPLC似乎足够灵敏,能够检测母体血浆样本中的少量胎儿DNA。它可能是用于非侵入性产前检测与视网膜病变相关的父系遗传点突变的有用工具。